Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphomaMichael R. Green, Margaret A. Shipp|Blood|2010Cited by 1.3k
Characteristics of anti-CD19 CAR T cell infusion products associated with efficacy and toxicity in patients with large B cell lymphomasQing Deng, Michael R. Green, Sattva S. Neelapu et al.|Nature Medicine|2020Cited by 593
Prognostic impact of corticosteroids on efficacy of chimeric antigen receptor T-cell therapy in large B-cell lymphomaPaolo Strati, Sattva S. Neelapu, Sairah Ahmed et al.|Blood|2021Cited by 213
Clinical efficacy of anakinra to mitigate CAR T-cell therapy–associated toxicity in large B-cell lymphomaPaolo Strati, Jason R. Westin, Sairah Ahmed et al.|Blood Advances|2020Cited by 195
Selective Inhibition of HDAC3 Targets Synthetic Vulnerabilities and Activates Immune Surveillance in LymphomaPatrizia Mondello, Michael R. Green, Saber Tadros et al.|Cancer Discovery|2020Cited by 159